Blaine Davis's Net Worth

$47.1 Thousand

Estimate Recalculated Jul 11, 2024 06:57PM EST

Who is Blaine Davis?

Blaine Davis does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Protara Therapeutics, Inc., and Cartesian Therapeutics, Inc..

SEC CIK

Blaine Davis's CIK is 0001802188

Past Insider Trading and Trends

2022 was Blaine Davis's most active year for acquiring shares with 3 total transactions. Blaine Davis's most active month to acquire stocks was the month of December. 2022 was Blaine Davis's most active year for disposing of shares, totalling 1 transactions. Blaine Davis's most active month to dispose stocks was the month of June. 2020 saw Blaine Davis paying a total of $25,037.79 for 95,481 shares, this is the most they've acquired in one year. In 2023 Blaine Davis cashed out on 1,250,000 shares for a total of $987,500.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Protara Therapeutics, Inc. (TARA) Snapshot price: $2.72

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-19.74%
-5.08K
$3.13
-$15,903.53
20.66K
Jul 15
Form 4
+952.06%
14.1K
—
—
15.58K
Jan 3
Form 4
—
0
—
—
0
Jan 19
Form 4
∞
1.48K
$16.91
$25,037.79
1.48K
Sep 22
Form 4
—
0
—
—
0
Feb 11
Form 3
—
0
—
—
0
No matching records found

Cartesian Therapeutics, Inc. (RNAC) Snapshot price: $0.6653

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.42M
—
—
2.42M
Jan 2
Form 4
—
0
—
—
0
Nov 13
Form 4
—
0
—
—
0
Nov 28
Form 3
—
0
—
—
0
No matching records found